Molecular Mode of Action of Juvenile Hormone Analogs

Grants and Contracts Details

Description

Adult insects such as mosquitoes transmit pathogens that cause deadly diseases in humans. Preventing adult emergence has been used as a strategy to block the transmission of pathogens. Juvenile hormones (JH) prevent metamorphosis and adult emergence; therefore, juvenile hormone analogs (JHA) such as methoprene, hydroprene, and pyriproxyfen have been commercialized for controlling mosquitoes and other vectors. However, the molecular mode of action of JHAs in killing mosquitoes and other insects remains poorly understood. JHAs are thought to act by preventing larval-pupal metamorphosis. This is precisely how this compound works in most lepidopteran insects. However, in dipteran insects such as the yellow fever mosquito, Aedes aegypti, JHA application to larvae does not prevent larval-pupal metamorphosis; the treated larvae undergo pupal ecdysis and die during the pupal stage. Preliminary studies showed that the pupae developed from methoprene treated larvae die because of the persistence of larval tissues. Transgenic CRISPR/Cas9 genome editing method was employed to knockout Ae. aegypti ortholog of the gene coding for ecdysone induced protein 93F (E93) which is known to regulate programmed cell death (PCD) of larval tissues. The phenotype of Ae aegypti E93 knockout animals is like that observed in JHA treated larvae suggesting that JHA suppresses E93 expression preventing the death of larval tissues producing pupae containing both larval and pupal tissues resulting in their death. This hypothesis will be tested by conducting experiments under two specific aims. In the first specific aim, larval tissues undergoing PCD will be examined to identify similarities and differences between JHA-treated and E93 knockout insects. The status of PCD in tissues dissected from JHA treated and E93 knockout larvae and pupae will be studied by staining with apoptosis and autophagy markers. In the second specific aim, RNA and ATAC sequencing, RNAi, reporter assays and RT-qPCR will be employed to identify critical genes involved in larval tissue remodeling and mechanisms of regulation of their expression by JHA working through E93. The function of E93 as a pioneer and/or as an activating transcription factor will be studied. Results from the proposed research will impact medicine by providing information for the development of vector control methods. The results from the proposed studies will answer long-standing questions on JHA action in mosquitoes and increase our understanding of JH action, which could help to develop novel, highly active, and safe methods to control mosquitoes and other vectors of pathogens.
StatusActive
Effective start/end date6/1/215/31/25

Funding

  • National Institute of Allergy and Infectious Diseases: $398,750.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.